Author:
Shang Zhen-Zi,Ye Hui-Yu,Gao Xin,Wang Hong-Yan,Li Qiang-Ming,Hu Jiang-Miao,Zhang Feng-Yun,Luo Jian-Ping
Funder
National Major Science and Technology Projects of China
Collaborative Innovation Project of Colleges and Universities of Anhui Province
National Aerospace Science Foundation of China
Reference52 articles.
1. Glucagon-like peptide 1 (GLP-1);Müller;Mol. Metab.,2019
2. Glucagon-like peptide 1 in health and disease;Andersen;Nat. Rev. Endocrinol.,2018
3. GLP-1 physiology informs the pharmacotherapy of obesity;Drucker;Mol. Metab.,2022
4. Obesity pharmacotherapy: incretin action in the central nervous system;Boer;Trends Pharmacol. Sci.,2023
5. DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits;Razavi;Mil. Med. Res.,2022